Serum Bilirubin Levels Can Predict Pancreatic and Biliary Malignancies in Patients with Obstructive Jaundice and Non-conclusive Cytology

Assad Khan¹, Snehal Lapsia², Mohammed Aslam², Vishal Kaushik³, Yogi Reddy³ and Daren Subar^1,

¹Department of Hepatobiliary and Pancreatic Surgery, East Lancashire Hospitals NHS Trust, Haslingden Road, Blackburn, UK, BB2 3HH

²Department of Radiology, East Lancashire Hospitals NHS Trust, Haslingden Road, Blackburn, UK, BB2 3HH

³Department of Gastroenterology, East Lancashire Hospitals NHS Trust, Haslingden Road, Blackburn, UK, BB2 3HH

Cite this paper:
Assad Khan, Snehal Lapsia, Mohammed Aslam, Vishal Kaushik, Yogi Reddy and Daren Subar. Serum Bilirubin Levels Can Predict Pancreatic and Biliary Malignancies in Patients with Obstructive Jaundice and Non-conclusive Cytology. Global Journal of Surgery. 2018; 6(1):11-15. doi: 10.12691/js-6-1-3

Abstract

Background: Elevated serum bilirubin has been shown to be a reliable predictor of pancreatic and biliary malignancy but the relationship between serum bilirubin and inadequate (C1), benign (C2) and indeterminate (C3) cellular samples has not been explored. The aim of this study is to determine the relationship between serum bilirubin and pancreatic, biliary or ampullary malignancy in the context of non-confirmatory cytology. Methods: This is a retrospective analysis of patients with obstructive jaundice undergoing investigation for possible pancreatic, peri-ampullary or biliary malignancy between 2009 and 2013. Results: 135 patients were included; 84 had a malignant diagnosis and 51 benign. All patients with C4 or C5 cytology (n=49) had confirmed malignancy. 35 out of 86 C1 – C3 samples were falsely negative. ROC curve analysis demonstrated a strong association (AUC 0.912) between elevated serum bilirubin and malignancy; serum bilirubin ≥ 100 µmol/L had a sensitivity of 86% and a specificity of 88%. In the C1-C3 subgroup, this association was maintained (AUC 0.905). Serum bilirubin ≥ 100 µmol/L had a sensitivity of 80% and specificity of 88%. Using this cut-off highlighted 28 out of 35 of the malignancies missed by cytology (p = 0.003). Conclusion: Our study demonstrates that a serum bilirubin ≥ 100 µmol/L is associated with malignancy and this relationship is maintained in C1-C3 cytology. When faced with non-confirmatory cytology in the absence of a benign aetiology and an elevated serum bilirubin ≥ 100 µmol/L, we advocate more aggressive investigation to avoid missing an occult malignancy.

Keywords:
bilirubin cytology pancreatic cancer adenocarcinoma

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Asbun, HJ, Conlon, K, Fernandez-Cruz, L, et al 2014. When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery, 155(5), pp. 887-892.
[2]	Fusaroli, P, Kypraios, D, Caletti, G et al., 2012. Pancreatico-biliary endoscopic ultrasound: a systematic review of the levels of evidence, performance and outcomes. World Journal of Gastroenterology: WJG, 18(32), p.4243.
[3]	Berberat, P.O., Ingold, H., Goblins, A., et al 2007. Fast track-different implications in pancreatic surgery. Journal of gastrointestinal surgery, 11(7), pp.880-887.
[4]	Oppong, K., Raine, D., Near, M., Wadehra, V., Ramakrishnan, S. and Charnley, R.M., 2010. EUS-FNA versus biliary brushings and assessment of simultaneous performance in jaundiced patients with suspected malignant obstruction. JOP. Journal of the Pancreas, 11(6), pp. 560-567.
[5]	Garcea, G., Ngu, W., Neal, C.P., Dennison, A.R. and Berry, D.P., 2011. Bilirubin levels predict malignancy in patients with obstructive jaundice. HPB, 13(6), pp. 426-430.
[6]	Vasilieva, L., Alexopoulou, A., Papadhimitriou, S.I., Romanos, A., Xynopoulos, D. and Dourakis, S.P., 2012. Total bilirubin is a good discriminator between benign and malignant biliary strictures. HPB, 14(1), p. 71.
[7]	Liu, C.L., Fan, S.T., Lo, C.M., Tso, W.K., Wong, Y., Poon, R.T.P., Lam, C.M., Wong, B.C. and Wong, J., 2005. Clinico‐biochemical prediction of biliary cause of acute pancreatitis in the era of endoscopic ultrasonography. Alimentary pharmacology & therapeutics, 22(5), pp. 423-431.
[8]	Thomasset, S.C., Saunders, D., Holland, A., Dennison, A.R. and Garcea, G., 2015. Malignant biliary strictures in patients with a normal bilirubin and/or normal liver enzymes. HPB, 17(11), pp. 969-974.
[9]	Kasapidis, P., Mironidis, L., Giannakopoulos, A., Delis, V., Balatsos, V., Konstantinidis, A. and Skandalis, N., 2008. Clinical discrimination between choledocholithiasis and biliopancreatic malignancy based on a new biochemical model. Annals of Gastroenterology, 21(2), pp.119-126.
[10]	Al-Mofleh, I. A., Aljebreen, A. M., Al-Amri, S. M., Al-Rashed, R. S., Al-Faleh, F. Z., Al-Freihi, H. M., ... & Isnani, A. C. (2004). Biochemical and radiological predictors of malignant biliary strictures. World journal of gastroenterology, 10(10), 1504.
[11]	Bain, V. G., Abraham, N., Jhangri, G. S., Alexander, T. W., Henning, R. C., Hoskinson, M. E., ... & Sadowski, D. C. (2000). Prospective study of biliary strictures to determine the predictors of malignancy. Canadian Journal of Gastroenterology and Hematology, 14(5), 397-402.
[12]	Bowlus, C.L., Olson, K.A. and Gershwin, M.E., 2016. Evaluation of indeterminate biliary strictures. Nature reviews. Gastroenterology & hepatology, 13(1), p. 28.
[13]	de Jong, K., Nio, C.Y., Mearadji, B., Phoa, S.S., Engelbrecht, M.R., Dijkgraaf, M.G., Bruno, M.J. and Fockens, P., 2012. Disappointing interobserver agreement among radiologists for a classifying diagnosis of pancreatic cysts using magnetic resonance imaging. Pancreas, 41(2), pp. 278-282.
[14]	Singh, A., Gelrud, A. and Agarwal, B., 2015. Biliary strictures: diagnostic considerations and approach. Gastroenterology report, 3(1), pp. 22-31.
[15]	Sultana, A., Jackson, R., Tim, G., Bostock, E., Psarelli, E. E., Cox, T. F., ... & Halloran, C. M. (2015). What is the best way to identify malignant transformation within pancreatic IPMN: a systematic review and meta-analyses. Clinical and translational gastroenterology, 6(12), e130.
[16]	Khashab, M. A., Kim, K., Lennon, A. M., Shin, E. J., Tignor, A. S., Amateau, S. K., ... & Canto, M. I. (2013). Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms. Pancreas, 42(4), 717-721.
[17]	Schema, W., Ba-Ssalamah, A., Kölblinger, C., Kulinna-Cosentini, C., Puespoek, A., & Götzinger, P. (2007). Pancreatic adenocarcinoma. European radiology, 17(3), 638-649.
[18]	Govil, H., Reddy, V., Kluskens, L., Treaba, D., Massarani-Wafai, R., Selvaggi, S., & Gattuso, P. (2002). Brush cytology of the biliary tract: retrospective study of 278 cases with histopathologic correlation. Diagnostic cytopathology, 26(5), 273-277.
[19]	Scheiman, J.M., Hwang, J.H. and Moayyedi, P., 2015. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology, 148(4), pp. 824-848.
[20]	Weilert, F., Bhat, Y.M., Binmoeller, K.F., Kane, S., Jaffee, I.M., Shaw, R.E., Cameron, R., Hashimoto, Y. and Shah, J.N., 2014. EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study. Gastrointestinal endoscopy, 80(1), pp. 97-104.
[21]	National Institute for Clinical Excellence (2018). Pancreatic cancer in adults; diagnosis and management [NG85]. Retrieved from: https://www.nice.org.uk/guidance/ng85.
[22]	Singh Saluja, S., Sharma, R., Pal, S., Sahni, P. and Kanti Chattopadhyay T, 2007. Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study. HPB, 9(5), pp. 373-382.
[23]	Ferreira, R., Loureiro, R., Nunes, N., Santos, A.A., Maio, R., Crave, M. and Duarte, M.A., 2016. Role of endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures: What’s new?. World journal of gastrointestinal endoscopy, 8(4), p. 220.
[24]	Navaneethan, U., Hasan, M. K., Lourdusamy, V., Njei, B., Varadarajulu, S., & Hawes, R. H. (2015). Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review. Gastrointestinal endoscopy, 82(4), 608-614.